Vaishali Pharma Limited (NSE:VAISHALI)

Vaishali Pharma Statistics

Total Valuation

Vaishali Pharma has a market cap or net worth of INR 1.09 billion. The enterprise value is 1.23 billion.

Market Cap	1.09B
Enterprise Value	1.23B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Vaishali Pharma has 130.46 million shares outstanding. The number of shares has increased by 10.66% in one year.

Current Share Class	130.46M
Shares Outstanding	130.46M
Shares Change (YoY)	+10.66%
Shares Change (QoQ)	+3.05%
Owned by Insiders (%)	47.17%
Owned by Institutions (%)	n/a
Float	67.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.93
PB Ratio	1.61
P/TBV Ratio	1.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-321.08
EV / Sales	1.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.23.

Current Ratio	2.37
Quick Ratio	1.11
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.59

Financial Efficiency

Return on equity (ROE) is -0.57% and return on invested capital (ROIC) is -3.15%.

Return on Equity (ROE)	-0.57%
Return on Assets (ROA)	-1.37%
Return on Invested Capital (ROIC)	-3.15%
Return on Capital Employed (ROCE)	-3.31%
Weighted Average Cost of Capital (WACC)	3.24%
Revenue Per Employee	43.46M
Profits Per Employee	-142,296
Employee Count	27
Asset Turnover	1.04
Inventory Turnover	54.93

Taxes

In the past 12 months, Vaishali Pharma has paid 1.03 million in taxes.

Income Tax	1.03M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.21% in the last 52 weeks. The beta is -0.31, so Vaishali Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.31
52-Week Price Change	-44.21%
50-Day Moving Average	8.80
200-Day Moving Average	11.24
Relative Strength Index (RSI)	43.86
Average Volume (20 Days)	288,515

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vaishali Pharma had revenue of INR 1.17 billion and -3.84 million in losses. Loss per share was -0.03.

Revenue	1.17B
Gross Profit	132.07M
Operating Income	-24.77M
Pretax Income	-2.81M
Net Income	-3.84M
EBITDA	-23.51M
EBIT	-24.77M
Loss Per Share	-0.03

Balance Sheet

The company has 10.46 million in cash and 156.01 million in debt, with a net cash position of -145.55 million or -1.12 per share.

Cash & Cash Equivalents	10.46M
Total Debt	156.01M
Net Cash	-145.55M
Net Cash Per Share	-1.12
Equity (Book Value)	673.82M
Book Value Per Share	5.11
Working Capital	643.50M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 11.25%, with operating and profit margins of -2.11% and -0.33%.

Gross Margin	11.25%
Operating Margin	-2.11%
Pretax Margin	-0.24%
Profit Margin	-0.33%
EBITDA Margin	-2.00%
EBIT Margin	-2.11%
FCF Margin	n/a

Dividends & Yields

Vaishali Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.66%
Shareholder Yield	-10.66%
Earnings Yield	-0.35%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 15, 2024. It was a forward split with a ratio of 10.

Last Split Date	Oct 15, 2024
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a